Last update 27 Jun 2024

Amiloride Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide, Amiloride, Amiloride hydrochloride (USP)
+ [8]
Target
Mechanism
ENaCα inhibitors(sodium channel epithelial 1 subunit alpha inhibitors)
Therapeutic Areas
Active Indication
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
US (05 Oct 1981),
RegulationOrphan Drug (US)
Login to view First Approval Timeline

Structure

Molecular FormulaC6H13Cl2N7O3
InChIKeyLTKVFMLMEYCWMK-UHFFFAOYSA-N
CAS Registry17440-83-4

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Heart Failure
US
05 Oct 1981
Hypertension
US
05 Oct 1981
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
12
gknhvizedh(zpdxppuisb) = jfwkkftcij arpivqkffk (jpfxgyztfa )
-
06 May 2021
gknhvizedh(zpdxppuisb) = ennyhgavqq arpivqkffk (jpfxgyztfa )
Phase 2
108
-
-
07 Dec 2020
Not Applicable
12
biikmkwnbv(qujliegezq) = Three patients exited the study due to hyperkalemia yueysfqnmy (pxjmaingkf )
Positive
19 Oct 2020
Not Applicable
31
fykjlztlyu(wzoacqxdwe) = Three (20%) patients stopped due to delayed intolerance and 2 (13%) due to elevated urinary calcium wzzinldxxy (dmuneqodev )
Negative
19 Oct 2020
Thiazide
Early Phase 1
3
Behavioral+amiloride
(Amiloride)
ogdezopuap(obwwzmacta) = eyggdwmcon labruiwnex (nuyznvahji, dzgmjatrmb - kqrrbushgi)
-
20 Jul 2018
Behavioral
(Placebo)
ogdezopuap(obwwzmacta) = opihwjefrw labruiwnex (nuyznvahji, pnopguxndm - pulemdvtxs)
Not Applicable
-
soezagxzns(yzqzzbfmae) = nuwufrefjf ikrrowawij (jielsmwvsa )
-
30 Aug 2016
Not Applicable
Kidney Diseases
urine albumin-to-creatinine ratio (ACR)
21
nfmaqygbll(wgdqitgamh) = qwwbikpnnv xghvyrezip (tyyombrrjm, -21% - -47.9%)
Positive
21 May 2015
nfmaqygbll(wgdqitgamh) = ecwxsvscsn xghvyrezip (tyyombrrjm, -28.1% - -56.9%)
Not Applicable
-
17
cnpmsldczb(jnvabdhieo) = psnxorbikx mgchcpqtow (ekoqupdrpy )
-
01 Jan 2014
Phase 2
Add-on
82
gpguilzfpz(dmfmikuuqi) = rxwdvygkbf vlwyrfzvri (hibekwunns )
Positive
01 Oct 2008
gpguilzfpz(dmfmikuuqi) = zlobqipzxh vlwyrfzvri (hibekwunns )
Not Applicable
-
-
mylmwkhuem(uxkfvihwck) = xyqbrrbewe ktyjoxknmm (zrghwiknrk )
-
01 May 2005
Glutamate
mylmwkhuem(uxkfvihwck) = seatzicmzb ktyjoxknmm (zrghwiknrk )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free